Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has issued an announcement.
Jubilant Pharmova Limited has announced the publication of its unaudited standalone and consolidated financial results for the quarter and half year ending September 30, 2025. These results, approved by the Board of Directors, are accessible to investors through newspaper publications and the company’s website, reflecting the company’s commitment to transparency and regulatory compliance.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company is known for its emphasis on innovation and quality, catering to both domestic and international markets.
Average Trading Volume: 8,445
Technical Sentiment Signal: Buy
Current Market Cap: 174.8B INR
Learn more about JUBLPHARMA stock on TipRanks’ Stock Analysis page.